Biphasic intrauterine growth in insulin-dependent diabetic pregnancies.
- 1 June 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 8 (3), 225-234
- https://doi.org/10.1080/07315724.1989.10720297
Abstract
Early fetal growth delay (7-14 weeks of gestation) has been reported in insulin-dependent diabetic (IDD) pregnancies and in several animal models. Macrosomia is a classic feature of the infant of the IDD mother. We hypothesized therefore that a biphasic pattern of fetal growth exists in IDD pregnancies. We compared fetal growth measurements [biparietal diameter (BPD) and abdominal circumference (AC)] obtained sonographically from 106 IDD pregnancies (Class B-RT) to similar data obtained from 117 normal, nondiabetic patients. The goals for diabetic glycemic control were: fasting blood sugar less than or equal to 100 mg/dl and postprandial blood sugar less than 140 mg/dl. From one to five ultrasonographic measurements were performed at varying gestational ages in all study patients. For data analysis, one examination from each pregnancy was randomly selected by computer. Gestational age (GA) was calculated from last menstrual period and corroborated by infant physical examination (Ballard score) at birth. BPD growth pattern was biphasic in the diabetic group, described by a cubic equation: BPD = 4.99 - 0.567GA + 0.037(GA)2 - 0.0005(GA)3, R2 = 0.935. Such a biphasic pattern did not exist in the control population [BPD = -3.0323 + 0.473(gestation) - (−0.0040)(gestation)2, R2 = 0.9173]. Early growth delay was greater in fetuses that subsequently developed macrosomia (p less than 0.01). Similar results were found for AC measurements. We conclude that fetal growth delay occurs in the first half of the IDD pregnancy, followed by a phase of increased growth. The mechanism of the early growth delay is unclear. We speculate that early growth delay may be due to a “toxic” effect of glucose or other metabolite; and subsequent increased growth relates to fetal hyperinsulinism which develops from weeks 15 to 20 of gestation.This publication has 30 references indexed in Scilit:
- Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in cultureDiabetes, 1986
- The Honeybee Syndrome — Implications of the Teratogenicity of Mannose in Rat-Embryo CultureNew England Journal of Medicine, 1984
- Relative fetal hypoxia as a contributing factor to fetal macrosomia in diabetic pregnancyMedical Hypotheses, 1983
- Factors Influencing Fetal Growth in Infants of Diabetic MothersJournal of Pediatric Gastroenterology and Nutrition, 1983
- A simplified score for assessment of fetal maturation of newly born infantsThe Journal of Pediatrics, 1979
- The Infant of the Diabetic MotherNew England Journal of Medicine, 1979
- Development of insulin secretion in the human fetus.Archives of Disease in Childhood, 1973
- WEIGHT AND LENGTH AT BIRTH OF INFANTS OF DIABETIC MOTHERSActa Endocrinologica, 1954
- THE INFANTS OF DIABETIC MOTHERSBJOG: An International Journal of Obstetrics and Gynaecology, 1953
- Hypertrophy and hyperplasia of the pancreatic islets in new‐born infantsThe Journal of Pathology and Bacteriology, 1953